Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
Background and Objectives High-dose melphalan and autologous stem cell transplantation is currently the treatment of choice for selected patients with AL amyloidosis; however, new treatments are needed for patients who are ineligible for or relapse after this procedure. Bortezomib is a proteasome in...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2007-10-01
|
| Col·lecció: | Haematologica |
| Accés en línia: | https://haematologica.org/article/view/4600 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|